Evidence map›Paper›PMID 39970206›Full record

ArticleScience advances2025

Sequence-dependent scale for translocon-mediated insertion of interfacial helices in membranes.

Brayan Grau, Rian Kormos, Manuel Bañó-Polo, Kehan Chen, María J García-Murria, Fatlum Hajredini, Manuel M Sánchez Del Pino, Hyunil Jo, Luis Martínez-Gil, Gunnar von Heijne and 2 more

Abstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Structural insights into SARS-CoV-2 nonstructural protein 4 (nsp4) biogenesis.Protein science : a publication of the Protein Society · 2025
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Brayan GrauInstitute for Biotechnology and Biomedicine (BIOTECMED), Department of Biochemistry and Molecular Biology, University of Valencia, E-46100 Burjassot, Spain.ORCID 0000-0002-8582-023X
Rian KormosDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0002-5831-1464
Manuel Bañó-PoloInstitute for Biotechnology and Biomedicine (BIOTECMED), Department of Biochemistry and Molecular Biology, University of Valencia, E-46100 Burjassot, Spain.ORCID 0000-0002-4840-4480
Kehan ChenDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0003-0419-8360
María J García-MurriaInstitute for Biotechnology and Biomedicine (BIOTECMED), Department of Biochemistry and Molecular Biology, University of Valencia, E-46100 Burjassot, Spain.
Fatlum HajrediniDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0003-0656-6059
Manuel M Sánchez Del PinoInstitute for Biotechnology and Biomedicine (BIOTECMED), Department of Biochemistry and Molecular Biology, University of Valencia, E-46100 Burjassot, Spain.ORCID 0000-0001-9696-7600
Hyunil JoDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0002-4863-0779
Luis Martínez-GilInstitute for Biotechnology and Biomedicine (BIOTECMED), Department of Biochemistry and Molecular Biology, University of Valencia, E-46100 Burjassot, Spain.ORCID 0000-0002-9076-7760
Gunnar von HeijneScience for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, SE-10691 Stockholm, Sweden.ORCID 0000-0002-4490-8569
William F DeGradoInstitute for Biotechnology and Biomedicine (BIOTECMED), Department of Biochemistry and Molecular Biology, University of Valencia, E-46100 Burjassot, Spain.ORCID 0000-0003-4745-263X
Ismael MingarroInstitute for Biotechnology and Biomedicine (BIOTECMED), Department of Biochemistry and Molecular Biology, University of Valencia, E-46100 Burjassot, Spain.ORCID 0000-0002-1910-1229

Funding

Deciphering the relationship between structure, dynamics and function in helical bundle proteinsR35GM122603 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WILLIAM DEGRADO · 2017 to 2026
$7.1M
NIGMS NIH HHS R35 GM122603
6 · The paper itself

Abstract

Biological membranes consist of a lipid bilayer studded with integral and peripheral membrane proteins. Most α-helical membrane proteins require protein-conducting insertases known as translocons to assist in their membrane insertion and folding. While the sequence-dependent propensities for a helix to either translocate through the translocon or insert into the membrane have been codified into numerical hydrophobicity scales, the corresponding propensity to partition into the membrane interface remains unrevealed. By engineering diagnostic glycosylation sites around test peptide sequences inserted into a host protein, we devised a system that can differentiate between water-soluble, surface-bound, and transmembrane (TM) states of the sequence based on its glycosylation pattern. Using this system, we determined the sequence-dependent propensities for transfer from the translocon to a TM, interfacial, or extramembrane space and compared these propensities with the corresponding probability distributions determined from the sequences and structures of experimentally determined proteins.

Indexed as

Cell MembraneLipid BilayersMembrane ProteinsAmino Acid SequenceGlycosylationHydrophobic and Hydrophilic InteractionsModels, MolecularProtein Conformation, alpha-HelicalLipid BilayersMembrane Proteins

Identifiers

PMID39970206
PMCPMC11837994

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.